Pathway inhibitors for bridging to allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL)

被引:0
|
作者
Hahn, M. [1 ]
Dietrich, S. [1 ]
Hain, S-A [2 ]
Hegenbart, U. [1 ]
Rieger, M.
Scheuer, B.
Ho, A. D. [1 ]
Dreger, P. [1 ]
机构
[1] Heidelberg Univ, Med Klin 5, Heidelberg, Germany
[2] St Marien Krankenhaus, Med Klin 3, Siegen, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V61
引用
收藏
页码:13 / 14
页数:2
相关论文
共 50 条
  • [21] Successful Treatment of Richter's Transformation with Ibrutinib in Patient with Chronic Lymphocytic Leukemia (CLL) Following Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
    Master, Samip
    Leary, Cheri
    Bozeman, Amy
    Peyton-Thomas, Breanne
    Devarakonda, Srinivas
    Takalkar, Amol
    Coltelingam, James
    Mansour, Richard
    Mills, Glenn
    Koshy, Nebu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S217 - S217
  • [22] Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemia
    Terwey T.H.
    Kim T.D.
    Arnold R.
    Current Hematologic Malignancy Reports, 2009, 4 (3) : 139 - 147
  • [23] Serum miRNA Expression and Allogeneic Stem Cell Transplantation in Patients with B Chronic Lymphocytic Leukemia (CLL)
    Khouri, Issa F.
    Anfossi, Simone
    Saliba, Rima M.
    St John, Lisa S.
    Molldrem, Jeffrey J.
    Reuben, James M.
    BLOOD, 2014, 124 (21)
  • [24] Allogeneic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia
    Atilla, Erden
    Atilla, Pinar Ataca
    Pekcan, Gultekin
    Ilhan, Osman
    Gurman, Gunhan
    Ozcan, Muhit
    Arslan, Onder
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S262 - S263
  • [25] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    Dreger, P
    Montserrat, E
    LEUKEMIA, 2002, 16 (06) : 985 - 992
  • [26] OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA
    Rashed, A.
    Corringham, S.
    Castro, J. E.
    Kipps, T. J.
    Ball, E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S295 - S295
  • [27] Allogeneic hematopoietic stem cell transplantation with nonmyeloablative conditioning for patients with chronic lymphocytic leukemia.
    Flowers, CR
    Maloney, DG
    Sandmaier, BM
    Shizuru, JA
    McSweeney, PA
    Chauncey, TR
    Niederwieser, D
    Sahebi, F
    Agura, E
    Blume, K
    Forman, S
    Storb, R
    BLOOD, 2001, 98 (11) : 418A - 418A
  • [28] Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for chronic lymphocytic leukemia
    Mohammad Faizan Zahid
    Natasha Ali
    Medical Oncology, 2015, 32
  • [29] Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
    P Dreger
    E Montserrat
    Leukemia, 2002, 16 : 985 - 992
  • [30] Bridging with Idelalisib appears safe in patients with chronic lymphocytic leukemia (CLL) prior to allogeneic hematopoietic stem cell transplantation (alloHCT): A Report from the EBMT Chronic Malignancies Working Party
    Schetelig, J.
    Chevallier, P.
    van Gelder, M.
    Hoek, J.
    Hermine, O.
    Thomson, K.
    Browne, P.
    Milpied, N.
    Russo, D.
    Socie, G.
    Rovira, M.
    Deconinck, E.
    Damaj, G.
    Cordonnier, C.
    Beelen, D.
    Leblond, V.
    Nikolousis, M.
    Stuhler, G.
    Mayer, J.
    Hunault-Berger, M.
    Bittenbring, J.
    Thieblemont, C.
    Lepetre, S.
    de Wreede, L. C.
    Dreger, P.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S99 - S100